Clinical Trial Update: Ga-68-FAPI-46 PET for CRC Recurrence Detection in Elevated CEA [NA]

View source ↗

Summary

Clinical trial evaluating Ga-68-FAPI-46 PET imaging for detecting colorectal cancer recurrence in patients with elevated CEA; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Ga-68-FAPI-46

Snippet

Sponsor: Koo Foundation Sun Yat-Sen Cancer Center | Conditions: Colorectal Cancer Recurrent | NA | Status: RECRUITING